# BIIB014 Cardiovascular Monitoring Study

> **NCT01035515** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** BIIB014 50mg
- **DRUG:** BIIB014 100mg

## Key facts

- **NCT ID:** NCT01035515
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035515, "BIIB014 Cardiovascular Monitoring Study". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01035515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*